Cytora
PrivateLast Round
Series B
Apr 17, 2019
Total Funding Raised
$41.72M
Company Overview
Cytora (Financial Software) is a technology company that offers a risk digitization and analytics platform to enhance underwriting processes in commercial insurance by utilizing artificial intelligence to analyze risk patterns and optimize pricing and selection.
Sector
FinTech
Verticals
InsurTech, Workflow Automation, Vertical SaaS, Compliance & Risk, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytora Comps
Public and private peers based on sector, stage, and business model.
Cytora Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 17, 2019 | ||||
| Series A | Dec 6, 2017 | ||||
| Seed | Jan 12, 2017 | ||||
| Pre Seed | Oct 1, 2015 | ||||
| Accelerator | Dec 3, 2013 |
Key People
Founding team and executive leadership
Cytora Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iLexIR | Seed |
| EQT Ventures | Series B |
| Starr Companies | Series A |
| QBE Ventures | Series A |
| Cambridge Enterprise | Seed, Series A, Pre Seed |
| Cambridge Innovation Capital | Series B, Series A |
| Cambridge Judge Business School | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Partnering with LexisNexis Risk Solutions for risk assessment and analytics.
- Apr 16, 2026
Arch Insurance now includes London Market operations in its partnership.
Cytora Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cytora's valuation, stock price, and market status.
